Informations:
Erreur:
ID
23140
Description
Responsible Party: C. R. Bard ClinicalTrials.gov Identifier: NCT02262949 History of Changes Other Study ID Numbers: BPV-13-002 DRKS00006281 ( Registry Identifier: Deutsches Register Klinischer Studien ) Study First Received: September 25, 2014 Last Updated: December 6, 2016 A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02262949
Lien
https://clinicaltrials.gov/ct2/show/NCT02262949
Mots-clés
Versions (1)
- 25/6/17 25/6/17 -
Téléchargé le
25 de junio de 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Vascular Stent in Peripheral Artery Disease DRKS00006281 NCT02262949 DRKS00006281
Eligibility Vascular Stent in Peripheral Artery Disease NCT02262949 DRKS00006281
Similar models
Eligibility Vascular Stent in Peripheral Artery Disease NCT02262949 DRKS00006281
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Informed Consent
Item
1. The subject or legal representative has been informed of the nature of the evaluation, agrees to its provisions, and has signed the informed consent form (ICF).
boolean
C0021430 (UMLS CUI [1])
Study Protocol
Item
2. Subject agrees to comply with the protocol-mandated follow-up procedures and visits.
boolean
C2348563 (UMLS CUI [1])
Age
Item
3. The subject is ≥ 21 years old.
boolean
C0001779 (UMLS CUI [1])
Pregnancy Test
Item
4. Female subjects of childbearing potential must have a negative urine or serum pregnancy test within seven days prior to index procedure. Female subjects who are surgically sterile or post-menopausal are exempt from having a pregnancy test.
boolean
C0032976 (UMLS CUI [1])
Mild Claudication
Item
5. The subject has lifestyle-limiting claudication or mild tissue loss defined as: Rutherford Category1 2-5 (moderate claudication to minor tissue loss).
boolean
C1456822 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C2945599 (UMLS CUI [1,2])
Peripheral angiography
Item
6. The target lesion has angiographic evidence of stenosis or restenosis ≥50% or occlusion in the SFA and/or popliteal artery (by visual estimate) and is amenable to PTA and stenting.
boolean
C0412290 (UMLS CUI [1])
Vessel diameter
Item
7. The target vessel reference diameter is (by visual estimate) appropriate for treatment with available stent diameters of 6.0 and 7.0 mm.
boolean
C1301408 (UMLS CUI [1])
Circulation
Item
8. There is angiographic evidence of at least one vessel runoff to the foot (at the level of the malleolus).
boolean
C0005775 (UMLS CUI [1])
Control Group
Item
0. Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Unwilling
Item
1. The subject is unable or unwilling to provide informed consent or is unable or unwilling to comply with the study follow-up procedure and visits.
boolean
C0558080 (UMLS CUI [1])
Claudication Specification
Item
2. The subject has claudication or critical limb ischemia described as Rutherford Category 0 (asymptomatic), 1 (mild claudication), or 6 (major tissue loss).
boolean
C1456822 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
Contraindication, Hypersensitivity
Item
3. The subject has a known contraindication (including allergic reaction) or sensitivity to antiplatelet/anticoagulant medication, nickel, titanium or tantalum.
boolean
C1301624 (UMLS CUI [1])
C0020517 (UMLS CUI [2])
C0020517 (UMLS CUI [2])
Contrast Media Allergy
Item
4. The subject has a known sensitivity to contrast media that is not amenable to pretreatment with steroids or/and antihistamines.
boolean
C0570562 (UMLS CUI [1])
Bleeding Disorder
Item
5. The subject has a history of bleeding diatheses of coagulopathy.
boolean
C0005779 (UMLS CUI [1])
Creatinine
Item
6. The subject has concomitant renal failure with a creatinine of >2.5 mg/dL.
boolean
C0201976 (UMLS CUI [1])
Hepatic insufficiency, thrombophlebitis, uremia, SLE, DVT
Item
7. The subject has concomitant hepatic insufficiency,thrombophlebitis, uremia, systemic lupus erythematosus (SLE), or deep vein thrombosis (DVT) at the time of the study procedure.Comorbidity
boolean
C0040046 (UMLS CUI [1])
C0041948 (UMLS CUI [2])
C0024141 (UMLS CUI [3])
C0149871 (UMLS CUI [4])
C0041948 (UMLS CUI [2])
C0024141 (UMLS CUI [3])
C0149871 (UMLS CUI [4])
Dialysis, Immunosuppressive Therapy
Item
8. The subject is receiving dialysis or immunosuppressive therapy.
boolean
C0011946 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C0021079 (UMLS CUI [2])
Study Participation Status
Item
9. The subject is participating in an investigational drug or another investigational device study.
boolean
C2348568 (UMLS CUI [1])
Comorbidity
Item
10. The subject has another medical condition, which, in the opinion of the investigator, may cause him/her to be noncompliant with the protocol, confound the data interpretation, or is associated with limited life expectancy of less than two years.
boolean
C0009488 (UMLS CUI [1])
Extensive peripheral vascular disease
Item
11. The subject has extensive peripheral vascular disease, which,in the opinion of the investigator, precludes safe insertion of an introducer sheath.
boolean
C0085096 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Aneurysm
Item
12. The target lesion is located within an aneurysm or associated with an aneurysm in the vessel segment either proximal or distal to the target lesion.
boolean
C0002940 (UMLS CUI [1])
Claudication with poor inflow
Item
13. The subject has angiographic evidence of poor inflow, which would be deemed inadequate to support a vascular bypass graft.
boolean
C1456822 (UMLS CUI [1,1])
C0806140 (UMLS CUI [1,2])
C0542537 (UMLS CUI [1,3])
C0806140 (UMLS CUI [1,2])
C0542537 (UMLS CUI [1,3])
Septicemia
Item
14. The subject is diagnosed with septicemia at the time of the study procedure.
boolean
C0036690 (UMLS CUI [1])
Previous Stenting
Item
15. Subjects with a stent previously implanted into the target lesion. A target vessel with a previously placed stent is permitted as long as the subject device will not come into contact with the previously placed stent during treatment of the target lesion.
boolean
C2348535 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,2])
Number of Stents
Item
16. Lesions requiring the use of more than one investigational stent.
boolean
C0038257 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
Bilateral disease
Item
17. Bilateral disease in the native SFA and/or proximal popliteal artery where both limbs meet the inclusion/exclusion criteria and it is planned to treat both limbs within 30 days.
boolean
C1511113 (UMLS CUI [1])